BG Medicine

NEW YORK (GenomeWeb News) – BG Medicine said in a document filed yesterday with the US Securities and Exchange Commission that it has laid off 12 of its 22 employees, or roughly 55 percent of its workforce.

NEW YORK (GenomeWeb News) – BG Medicine today reported second quarter revenues of $799,000, down 20 percent from $1.0 million in the second quarter of 2013.

NEW YORK (GenomeWeb News) – BG Medicine this week posted first quarter revenues of $739,000, down 17 percent from $888,000 in the first quarter of 2013.

NEW YORK (GenomeWeb News) – BG Medicine today reported first quarter revenues of $739,000, down 17 percent from $888,000 in the first quarter of 2013.

NEW YORK (GenomeWeb News) – BG Medicine today priced a public offering of common stock that is anticipated to bring in $8.9 million in net proceeds.

BG Medicine this week announced results from an analysis of three multicenter clinical research trials that indicate its BGM Galectin-3 test is predictive of rehospitalization for heart failure within the first 30 days following discharge from an initial hospital stay.

BG Medicine this week reported a 7 percent increase year over year in revenues for the fourth quarter.

NEW YORK (GenomeWeb News) – BG Medicine today reported a 7 percent increase year over year in revenues for the fourth quarter.

BG Medicine said this week that is compliant with requirements for listing on the Nasdaq Capital Market.

BG Medicine noted this week the publication of a study validating the analytical and clinical performance of an automated version of its BGM Galectin-3 heart failure test.

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.